1 곽미경(Kwak, Mi Kyong), "항암화학요법으로 인한 암환자의 말초신경병증 관련 특성과 삶의 질" 대한종양간호학회 10 (10): 231-239, 2010
2 김정혜, "항암화학요법으로 인한 말초신경병증을 경험하는 대장암 환자의 삶의 질" 대한종양간호학회 11 (11): 254-262, 2011
3 "http://www.questdiagnostics. com/testcenter/testguide.action?dc=WP_LabDiag nosis_Peri pheralNeurop#Immune Mediated Peripheral Neuropathies"
4 Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group" 5 : 649-655, 1982
5 Miller AB, "Reporting results of cancer treatment" 47 : 207-214, 1981
6 김혜영, "Reliability and Validity of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to Assess Chemotherapy-induced Peripheral Neuropathy" 한국간호과학회 44 (44): 735-742, 2014
7 Forsyth PA, "Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing" 35 (35): 47-53, 1997
8 Berger T, "Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy" 33 (33): 1393-1399, 1997
9 Cavaletti G, "Multi-center assessment of he Total Neuropathy Score for chemotherapy-induced peripheral eurotoxicity" 11 : 135-141, 2006
10 Lord RS, "Laboratory evaluations for integrative and functional medicine" Metametrix Institute 2008
1 곽미경(Kwak, Mi Kyong), "항암화학요법으로 인한 암환자의 말초신경병증 관련 특성과 삶의 질" 대한종양간호학회 10 (10): 231-239, 2010
2 김정혜, "항암화학요법으로 인한 말초신경병증을 경험하는 대장암 환자의 삶의 질" 대한종양간호학회 11 (11): 254-262, 2011
3 "http://www.questdiagnostics. com/testcenter/testguide.action?dc=WP_LabDiag nosis_Peri pheralNeurop#Immune Mediated Peripheral Neuropathies"
4 Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group" 5 : 649-655, 1982
5 Miller AB, "Reporting results of cancer treatment" 47 : 207-214, 1981
6 김혜영, "Reliability and Validity of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to Assess Chemotherapy-induced Peripheral Neuropathy" 한국간호과학회 44 (44): 735-742, 2014
7 Forsyth PA, "Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing" 35 (35): 47-53, 1997
8 Berger T, "Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy" 33 (33): 1393-1399, 1997
9 Cavaletti G, "Multi-center assessment of he Total Neuropathy Score for chemotherapy-induced peripheral eurotoxicity" 11 : 135-141, 2006
10 Lord RS, "Laboratory evaluations for integrative and functional medicine" Metametrix Institute 2008
11 Orgacka h, "Excretion of vanillic acid and homovanillic acid and tissue distribution of catecholamines and their metabolites in mice with various levels of pigmentation" 42 (42): 471-479, 1991
12 Du Bois A, "Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy" 7 (7): 354-361, 1999
13 Choie MH, "Effects of reflexology foot massage to improve quality of life and reduce anxiety for hospitalized cancer patients undergoing chemotherapy or radioisotope therapy" 14 : 61-74, 2009
14 Usha KM, "Diagnostic approach to peripheral neuropathy" 11 (11): 89-97, 2008
15 Housheer FH, "Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy" 33 : 15-49, 2006
16 Tofthagen CS, "Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool" 34 (34): E10-E20, 2011
17 Ajani JA, "Comprehensive criteria for assessing therapy-induced toxicity" 8 : 147-159, 1990
18 Wolf S, "Chemotherapy-induced peripheral neuropathy : prevention and treatment strategies" 44 (44): 1507-1515, 2008
19 Windebank AJ, "Chemotherapy-induced neuropathy" 13 (13): 27-46, 2008
20 Thomas N. Seyfried, "Cancer as a Metabolic Disease" 35 (35): 515-527, 2014
국립중앙도서관 "우편 복사 서비스"로 연결 됩니다.
DBpia
